ResearchMoz

Deep Analysis on Alpha-Mannosidosis Global Clinical Trials Review, H1, 2014

Researchmoz presents this most up-to-date research on"Alpha-Mannosidosis Global Clinical Trials Review, H1, 2014". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

 

Albany, NY -- (SBWIRE) -- 05/13/2014 -- Researchmoz presents this most up-to-date research on"Alpha-Mannosidosis Global Clinical Trials Review, H1, 2014". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

Alpha-Mannosidosis Global Clinical Trials Review, H1, 2014" provides data on the Alpha-Mannosidosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha-Mannosidosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alpha-Mannosidosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Browse Detail Report With TOC @ http://www.researchmoz.us/alpha-mannosidosis-global-clinical-trials-review-h1-2014-report.html

Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Browse Metabolic Disorders Related Research Reports @ http://www.researchmoz.us/metabolic-disorders-market-reports-14.html

Table of Contents
List of Tables
List of Figures 4
Introduction 5
Alpha-Mannosidosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Clinical Trials by G7 Countries: Proportion of Alpha-Mannosidosis to Metabolic Disorders Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Clinical Trials by End Point Status 17
Unaccomplished Trials of Alpha-Mannosidosis 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20

For More Information Kindly Contact:
Email: sales@researchmoz.us
Web Site: http://www.researchmoz.us/
Blog: http://globalandchinamarket.blogspot.com